The invention is related to the pharmaceutical industry and medicine and provides a new composition of a pharmaceutical product having a sedative effect to reduce excitability of the central nervous system. The invention claims a pharmaceutical product based on a dense valerian extract, in the form of a tablet, comprising a combination of a therapeutically efficient amount of dense valerian extract with excipients. The components of the pharmaceutical product are taken in the following proportion, parts by mass : dense extract of valerian rhizomes with roots (Valerianae rhizomata cumradicibus) 0.93-1.028; calcium hydrophosphate dihydrate 1.41-1.63; cross-carmellose sodium 0.28-0.33; microcrystalline cellulose 0.28-0.33; medical talc 0.028-0.033; magnesium stearate 0.028-0.033.